Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 1.6. It has been cited 41 times, with 38 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.561
From this paper's citation signal
Citation Network Contribution
1.1
From 29 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 38 citers.
National Institutes of Health
Grant: 1P01CA210961-01A1
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
Fields of Study
Sustainable Development Goals